About Cambridge Cognition
Cambridge Cognition is a company based in Cambridge (United Kingdom) founded in 2002. Cambridge Cognition has completed 2 acquisitions, including Clinpal and Winterlight Labs. Cambridge Cognition offers products and services including CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralized Clinical Trials. Cambridge Cognition operates in a competitive market with competitors including BrainCheck, Thymia, Cognivue, NEUROPHET and Altoida, among others.
- Headquarter Cambridge, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cambridge Cognition Holdings Plc
-
Annual Revenue
$12.96 M (USD)-23.48as on Dec 31, 2024
-
Net Profit
-$2.23 M (USD)49.12as on Dec 31, 2024
-
EBITDA
-$900.86 K (USD)51.25as on Dec 31, 2024
-
Latest Funding Round
$3.27 M (USD), Post-IPO
Mar 01, 2019
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Clinpal
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cambridge Cognition
Cambridge Cognition is a publicly listed company on the LSE with ticker symbol COG in UK, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cambridge Cognition
Cambridge Cognition offers a comprehensive portfolio of products and services, including CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralized Clinical Trials.
Digital tool for sensitive cognitive evaluations in clinical trials.
Automated system for scoring verbal cognitive tests accurately.
Platform for digital administration of research questionnaires.
Tasks for regular cognitive function tracking in studies.
End-to-end platform for remote trial data collection.
Funding Insights of Cambridge Cognition
Investments & Acquisitions by Cambridge Cognition
Cambridge Cognition has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Clinpal and Winterlight Labs.
Investment portfolio details for Cambridge Cognition
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cognitive impairment signs are detected through speech sample analysis.
|
Locked | Locked | 2015 | Locked | |
|
Technology and consulting for clinical trials industry are provided.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Cambridge Cognition
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cambridge Cognition
Detailed financials for Cambridge Cognition
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cambridge Cognition Comparisons
Peer comparison for Cambridge Cognition
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cambridge Cognition
Cambridge Cognition operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BrainCheck, Thymia, Cognivue, NEUROPHET and Altoida, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cognitive health is tracked via mobile interactive games.
|
|
| Locked | Locked | Locked |
AI-based video games are developed for mental health assessments.
|
|
| Locked | Locked | Locked |
Offering embedded vision processing solutions
|
|
| Locked | Locked | Locked |
AI-based simulation software for electrical brain stimulation is developed.
|
|
| Locked | Locked | Locked |
Provider of a AI-based app which can predict the onset of Alzheimer's
|
|
| Locked | Locked | Locked |
A wearable device for brain analysis and assessment is provided.
|
Detailed competitors of Cambridge Cognition
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cambridge Cognition
Complete news archive for Cambridge Cognition
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cambridge Cognition
Cambridge Cognition was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Cambridge Cognition is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Annual revenue of Cambridge Cognition is $12.96M as on Dec 31, 2024.
Computerized neuropsychological tests for cognitive assessment are provided by Cambridge Cognition, founded in 2002 in Cambridge, United Kingdom. Operations center on tools that aid diagnosis and treatment of neurological and psychiatric disorders. CANTAB Mobile serves as a screening application for early memory impairment linked to Alzheimers disease. CANTAB Insight evaluates brain function across cognitive domains, while CANTAB Recruit functions as an online platform for identifying clinical trial participants.
Cambridge Cognition's top competitors include BrainCheck, NEUROPHET and Altoida.
Cambridge Cognition offers CANTAB, Voice Analysis, Electronic Questionnaires, High Frequency Testing, and Decentralized Clinical Trials.
Yes, Cambridge Cognition is publicly traded on LSE under the ticker symbol COG.
Cambridge Cognition has made 2 acquisitions, including Clinpal, and Winterlight Labs.
The ticker symbol of Cambridge Cognition is COG on LSE.